{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:22:26Z","timestamp":1790626946923,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09860,20K08904,23K07988"],"award-info":[{"award-number":["17K09860,20K08904,23K07988"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04177,20H03675,and 23K27595"],"award-info":[{"award-number":["17H04177,20H03675,and 23K27595"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020964","name":"MEXT | JST | Fusion Oriented REsearch for disruptive Science and Technology","doi-asserted-by":"publisher","award":["JPMJFR235F"],"award-info":[{"award-number":["JPMJFR235F"]}],"id":[{"id":"10.13039\/501100020964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ym0126013h0001,23ym0126074h0002"],"award-info":[{"award-number":["21ym0126013h0001,23ym0126074h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0210202h0001"],"award-info":[{"award-number":["24ek0210202h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24am0521009"],"award-info":[{"award-number":["24am0521009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008664","name":"Ono Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Muscular dystrophy is a group of diseases characterized by progressive weakness and degeneration of skeletal muscles, for which there is currently no cure. Here, we show that microRNA (miR)-33a\/b play a crucial role in muscle regeneration. miR-33a was upregulated during myoblast differentiation and in skeletal muscles of\n                    <jats:italic>mdx<\/jats:italic>\n                    mice, a genetic model of Duchenne muscular dystrophy (DMD). miR-33a deficiency enhanced muscle regeneration response to cardiotoxin injury and attenuated muscle degeneration and fibrosis in\n                    <jats:italic>mdx<\/jats:italic>\n                    mice. Conversely, a humanized mouse model expressing miR-33a and miR-33b showed exacerbated muscle degeneration and fibrosis. Mechanistically, miR-33a\/b inhibited satellite cell proliferation, leading to reduced muscle regeneration and increased fibrosis by targeting\n                    <jats:italic>Cdk6<\/jats:italic>\n                    ,\n                    <jats:italic>Fst<\/jats:italic>\n                    , and\n                    <jats:italic>Abca1<\/jats:italic>\n                    . Local and systemic administration of anti-miRNA oligonucleotides targeting miR-33a\/b ameliorated the dystrophic phenotype in\n                    <jats:italic>mdx<\/jats:italic>\n                    mice. Furthermore, miR-33b inhibition upregulated these target genes in myotubes differentiated from human induced pluripotent stem cells derived from a patient with DMD. These findings indicate that miR-33a\/b are involved in muscle regeneration and their inhibition may represent a potential therapeutic strategy for muscular dystrophy.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00273-9","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:02:57Z","timestamp":1753232577000},"page":"1902-1925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration"],"prefix":"10.1038","volume":"17","author":[{"given":"Naoya","family":"Sowa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6766-750X","authenticated-orcid":false,"given":"Takahiro","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0992-064X","authenticated-orcid":false,"given":"Takeshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-1375","authenticated-orcid":false,"given":"Shigenobu","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tsujisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-0906","authenticated-orcid":false,"given":"Tomohide","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kotera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Takemiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-9795","authenticated-orcid":false,"given":"Yuuya","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Obika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4163-980X","authenticated-orcid":false,"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"85","key":"273_CR1","first-page":"51303","volume":"27","author":"A Aartsma-Rus","year":"2014","unstructured":"Aartsma-Rus A, van Putten M (2014) Assessing functional performance in the mdx mouse model. J Vis Exp 27(85):51303","journal-title":"J Vis Exp"},{"key":"273_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0960-8966(94)90071-X","volume":"4","author":"C Angelini","year":"1994","unstructured":"Angelini C, Fanin M, Pegoraro E, Freda MP, Cadaldini M, Martinello F (1994) Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes. Neuromuscul Disord 4:349\u2013358","journal-title":"Neuromuscul Disord"},{"key":"273_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamaneurol.2013.4908","volume":"71","author":"K Anthony","year":"2014","unstructured":"Anthony K, Arechavala-Gomeza V, Ricotti V, Torelli S, Feng L, Janghra N, Tasca G, Guglieri M, Barresi R, Armaroli A et al (2014) Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping. JAMA Neurol 71:32\u201340","journal-title":"JAMA Neurol"},{"key":"273_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.876078","volume":"13","author":"MH Baig","year":"2022","unstructured":"Baig MH, Ahmad K, Moon JS, Park SY, Ho Lim J, Chun HJ, Qadri AF, Hwang YC, Jan AT, Ahmad SS et al (2022) Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol 13:876078","journal-title":"Front Physiol"},{"key":"273_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3727\/096368908784153913","volume":"17","author":"BF Benabdallah","year":"2008","unstructured":"Benabdallah BF, Bouchentouf M, Rousseau J, Bigey P, Michaud A, Chapdelaine P, Scherman D, Tremblay JP (2008) Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transpl 17:337\u2013350","journal-title":"Cell Transpl"},{"key":"273_CR6","doi-asserted-by":"crossref","unstructured":"Bi X, Vitali C, Cuchel M (2015) ABCA1 and inflammation: from animal models to humans. Arterioscler Thromb Vasc Biol 35:1551\u20131553","DOI":"10.1161\/ATVBAHA.115.305547"},{"key":"273_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0006-291X(02)00303-0","volume":"293","author":"C Buechler","year":"2002","unstructured":"Buechler C, Boettcher A, Bared SM, Probst MC, Schmitz G (2002) The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin\/utrophin complex. Biochem Biophys Res Commun 293:759\u2013765","journal-title":"Biochem Biophys Res Commun"},{"key":"273_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1083\/jcb.200911036","volume":"190","author":"JF Chen","year":"2010","unstructured":"Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, Wang DZ (2010) microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190:867\u2013879","journal-title":"J Cell Biol"},{"key":"273_CR9","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.2527\/jas.2016-0532","volume":"94","author":"PR Chen","year":"2016","unstructured":"Chen PR, Lee K (2016) INVITED REVIEW: inhibitors of myostatin as methods of enhancing muscle growth and development. J Anim Sci 94:3125\u20133134","journal-title":"J Anim Sci"},{"key":"273_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.4161\/cc.11.5.19421","volume":"11","author":"D Cirera-Salinas","year":"2012","unstructured":"Cirera-Salinas D, Pauta M, Allen RM, Salerno AG, Ram\u00edrez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion MA, Morales-Ruiz M, Suarez Y et al (2012) Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 11:922\u2013933","journal-title":"Cell Cycle"},{"key":"273_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng0593-87","volume":"4","author":"GA Cox","year":"1993","unstructured":"Cox GA, Phelps SF, Chapman VM, Chamberlain JS (1993) New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet 4:87\u201393","journal-title":"Nat Genet"},{"key":"273_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-61779-343-1_2","volume":"798","author":"ME Danoviz","year":"2012","unstructured":"Danoviz ME, Yablonka-Reuveni Z (2012) Skeletal muscle satellite cells: background and methods for isolation and analysis in a primary culture system. Methods Mol Biol 798:21\u201352","journal-title":"Methods Mol Biol"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Prim 7:13","journal-title":"Nat Rev Dis Prim"},{"key":"273_CR14","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, Rudnicki MA (2015) Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 21:1455\u20131463","journal-title":"Nat Med"},{"key":"273_CR15","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","volume":"27","author":"L Echevarr\u00eda","year":"2018","unstructured":"Echevarr\u00eda L, Aupy P, Goyenvalle A (2018) Exon-skipping advances for Duchenne muscular dystrophy. Hum Mol Genet 27:R163\u2013R172","journal-title":"Hum Mol Genet"},{"key":"273_CR16","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.celrep.2015.07.066","volume":"12","author":"AA Fiorillo","year":"2015","unstructured":"Fiorillo AA, Heier CR, Novak JS, Tully CB, Brown KJ, Uaesoontrachoon K, Vila MC, Ngheim PP, Bello L, Kornegay JN et al (2015) TNF-\u03b1-induced microRNAs control dystrophin expression in becker muscular dystrophy. Cell Rep 12:1678\u20131690","journal-title":"Cell Rep"},{"key":"273_CR17","first-page":"197","volume":"52","author":"SC Froehner","year":"1997","unstructured":"Froehner SC, Adams ME, Peters MF, Gee SH (1997) Syntrophins: modular adapter proteins at the neuromuscular junction and the sarcolemma. Soc Gen Physiol Ser 52:197\u2013207","journal-title":"Soc Gen Physiol Ser"},{"key":"273_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1083\/jcb.201007165","volume":"192","author":"Y Ge","year":"2011","unstructured":"Ge Y, Sun Y, Chen J (2011) IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol 192:69\u201381","journal-title":"J Cell Biol"},{"key":"273_CR19","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","volume":"297","author":"H Gilson","year":"2009","unstructured":"Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP (2009) Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 297:E157\u2013164","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"273_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","volume":"22","author":"S Goel","year":"2022","unstructured":"Goel S, Bergholz JS, Zhao JJ (2022) Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer 22:356\u2013372","journal-title":"Nat Rev Cancer"},{"issue":"119","key":"273_CR21","first-page":"54515","volume":"1","author":"O Guardiola","year":"2017","unstructured":"Guardiola O, Andolfi G, Tirone M, Iavarone F, Brunelli S, Minchiotti G (2017) Induction of acute skeletal muscle regeneration by cardiotoxin injection. J Vis Exp 1(119):54515","journal-title":"J Vis Exp"},{"key":"273_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","volume":"34","author":"S Guiraud","year":"2017","unstructured":"Guiraud S, Davies KE (2017) Pharmacological advances for treatment in Duchenne muscular dystrophy. Curr Opin Pharm 34:36\u201348","journal-title":"Curr Opin Pharm"},{"key":"273_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10981","volume":"7","author":"G Han","year":"2016","unstructured":"Han G, Gu B, Cao L, Gao X, Wang Q, Seow Y, Zhang N, Wood MJ, Yin H (2016) Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice. Nat Commun 7:10981","journal-title":"Nat Commun"},{"key":"273_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1172\/JCI81655","volume":"126","author":"SM Hindi","year":"2016","unstructured":"Hindi SM, Kumar A (2016) TRAF6 regulates satellite stem cell self-renewal and function during regenerative myogenesis. J Clin Invest 126:151\u2013168","journal-title":"J Clin Invest"},{"key":"273_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919\u2013928","journal-title":"Cell"},{"key":"273_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.003376","volume":"1","author":"T Horie","year":"2012","unstructured":"Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, Horiguchi M, Nakamura T, Chonabayashi K, Hishizawa M et al (2012) MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice. J Am Heart Assoc 1:e003376","journal-title":"J Am Heart Assoc"},{"key":"273_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5551\/jat.20859","volume":"21","author":"T Horie","year":"2014","unstructured":"Horie T, Baba O, Kuwabara Y, Yokode M, Kita T, Kimura T, Ono K (2014a) MicroRNAs and lipoprotein metabolism. J Atheroscler Thromb 21:17\u201322","journal-title":"J Atheroscler Thromb"},{"key":"273_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21107-5","volume":"12","author":"T Horie","year":"2021","unstructured":"Horie T, Nakao T, Miyasaka Y, Nishino T, Matsumura S, Nakazeki F, Ide Y, Kimura M, Tsuji S, Rodriguez RR et al (2021) microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity. Nat Commun 12:843","journal-title":"Nat Commun"},{"key":"273_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep05312","volume":"4","author":"T Horie","year":"2014","unstructured":"Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y et al (2014b) MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci Rep 4:5312","journal-title":"Sci Rep"},{"key":"273_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3883","volume":"4","author":"T Horie","year":"2013","unstructured":"Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N, Yahagi N et al (2013) MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun 4:2883","journal-title":"Nat Commun"},{"key":"273_CR31","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1073\/pnas.1008499107","volume":"107","author":"T Horie","year":"2010","unstructured":"Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y et al (2010a) MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA 107:17321\u201317326","journal-title":"Proc Natl Acad Sci USA"},{"key":"273_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/cvr\/cvq148","volume":"87","author":"T Horie","year":"2010","unstructured":"Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E et al (2010b) Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res 87:656\u2013664","journal-title":"Cardiovasc Res"},{"key":"273_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49624-w","volume":"9","author":"T Kimura","year":"2019","unstructured":"Kimura T, Ferran B, Tsukahara Y, Shang Q, Desai S, Fedoce A, Pimentel DR, Luptak I, Adachi T, Ido Y et al (2019) Production of adeno-associated virus vectors for in vitro and in vivo applications. Sci Rep 9:13601","journal-title":"Sci Rep"},{"key":"273_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012609","volume":"8","author":"S Koyama","year":"2019","unstructured":"Koyama S, Horie T, Nishino T, Baba O, Sowa N, Miyasaka Y, Kuwabara Y, Nakao T, Nishiga M, Nishi H et al (2019) Identification of differential roles of microRNA-33a and -33b during atherosclerosis progression with genetically modified mice. J Am Heart Assoc 8:e012609","journal-title":"J Am Heart Assoc"},{"key":"273_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","volume":"4","author":"HL Li","year":"2015","unstructured":"Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H et al (2015) Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Rep 4:143\u2013154","journal-title":"Stem Cell Rep"},{"key":"273_CR36","doi-asserted-by":"publisher","first-page":"BSR20191327","DOI":"10.1042\/BSR20191327","volume":"40","author":"X Li","year":"2020","unstructured":"Li X, Qiu J, Liu H, Deng Y, Hu S, Hu J, Wang Y, Wang J (2020) MicroRNA-33a negatively regulates myoblast proliferation by targeting IGF1, follistatin and cyclin D1. Biosci Rep 40:BSR20191327","journal-title":"Biosci Rep"},{"key":"273_CR37","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1172\/JCI62656","volume":"122","author":"N Liu","year":"2012","unstructured":"Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 122:2054\u20132065","journal-title":"J Clin Invest"},{"key":"273_CR38","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(22)00125-9","volume":"21","author":"T Markati","year":"2022","unstructured":"Markati T, Oskoui M, Farrar MA, Duong T, Goemans N, Servais L (2022) Emerging therapies for Duchenne muscular dystrophy. Lancet Neurol 21:814\u2013829","journal-title":"Lancet Neurol"},{"key":"273_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1083\/jcb.200207056","volume":"162","author":"S McCroskery","year":"2003","unstructured":"McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135\u20131147","journal-title":"J Cell Biol"},{"key":"273_CR40","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F et al (2017) Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390:1489\u20131498","journal-title":"Lancet"},{"key":"273_CR41","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3233\/JND-210643","volume":"8","author":"CM McDonald","year":"2021","unstructured":"McDonald CM, Shieh PB, Abdel-Hamid HZ, Connolly AM, Ciafaloni E, Wagner KR, Goemans N, Mercuri E, Khan N, Koenig E et al (2021) Open-label evaluation of eteplirsen in patients with Duchenne muscular dystrophy amenable to exon 51 skipping: PROMOVI trial. J Neuromuscul Dis 8:989\u20131001","journal-title":"J Neuromuscul Dis"},{"key":"273_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.yexcr.2007.09.012","volume":"314","author":"C McFarlane","year":"2008","unstructured":"McFarlane C, Hennebry A, Thomas M, Plummer E, Ling N, Sharma M, Kambadur R (2008) Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp Cell Res 314:317\u2013329","journal-title":"Exp Cell Res"},{"key":"273_CR43","doi-asserted-by":"publisher","first-page":"e202301902","DOI":"10.26508\/lsa.202301902","volume":"6","author":"S Miyagawa","year":"2023","unstructured":"Miyagawa S, Horie T, Nishino T, Koyama S, Watanabe T, Baba O, Yamasaki T, Sowa N, Otani C, Matsushita K et al (2023) Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis. Life Sci Alliance 6:e202301902","journal-title":"Life Sci Alliance"},{"issue":"86","key":"273_CR44","first-page":"50846","volume":"8","author":"N Motohashi","year":"2014","unstructured":"Motohashi N, Asakura Y, Asakura A (2014) Isolation, culture, and transplantation of muscle satellite cells. J Vis Exp 8(86):50846","journal-title":"J Vis Exp"},{"key":"273_CR45","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, N\u00e4\u00e4r AM (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328:1566\u20131569","journal-title":"Science"},{"key":"273_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1096\/fj.07-8673com","volume":"22","author":"M Nakatani","year":"2008","unstructured":"Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S et al (2008) Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 22:477\u2013487","journal-title":"FASEB J"},{"key":"273_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/CIRCRESAHA.116.309528","volume":"120","author":"M Nishiga","year":"2017","unstructured":"Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H et al (2017) MicroRNA-33 controls adaptive fibrotic response in the remodeling heart by preserving lipid raft cholesterol. Circ Res 120:835\u2013847","journal-title":"Circ Res"},{"key":"273_CR48","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/ATVBAHA.118.311409","volume":"38","author":"T Nishino","year":"2018","unstructured":"Nishino T, Horie T, Baba O, Sowa N, Hanada R, Kuwabara Y, Nakao T, Nishiga M, Nishi H, Nakashima Y et al (2018) SREBF1\/microRNA-33b axis exhibits potent effect on unstable atherosclerotic plaque formation in vivo. Arterioscler Thromb Vasc Biol 38:2460\u20132473","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"273_CR49","doi-asserted-by":"publisher","first-page":"e135576","DOI":"10.1172\/jci.insight.135576","volume":"5","author":"P Podkalicka","year":"2020","unstructured":"Podkalicka P, Mucha O, Bronisz-Budzy\u0144ska I, Kozakowska M, Pietraszek-Gremplewicz K, Cetnarowska A, G\u0142owniak-Kwitek U, Bukowska-Strakova K, Cie\u015bla M, Kulecka M et al (2020) Lack of miR-378 attenuates muscular dystrophy in mdx mice. JCI Insight 5:e135576","journal-title":"JCI Insight"},{"key":"273_CR50","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI57275","volume":"121","author":"KJ Rayner","year":"2011","unstructured":"Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y et al (2011) Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 121:2921\u20132931","journal-title":"J Clin Invest"},{"key":"273_CR51","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ, Su\u00e1rez Y, D\u00e1valos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fern\u00e1ndez-Hernando C (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570\u20131573","journal-title":"Science"},{"key":"273_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer JrHB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR (2016) Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13:48\u201360","journal-title":"Nat Rev Cardiol"},{"key":"273_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/nan.12735","volume":"47","author":"P Soblechero-Mart\u00edn","year":"2021","unstructured":"Soblechero-Mart\u00edn P, L\u00f3pez-Mart\u00ednez A, de la Puente-Ovejero L, Vallejo-Illarramendi A, Arechavala-Gomeza V (2021) Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies. Neuropathol Appl Neurobiol 47:711\u2013723","journal-title":"Neuropathol Appl Neurobiol"},{"key":"273_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40259-023-00632-3","volume":"38","author":"S Szwec","year":"2024","unstructured":"Szwec S, Kap\u0142ucha Z, Chamberlain JS, Konieczny P (2024) Dystrophin- and utrophin-based therapeutic approaches for treatment of Duchenne muscular dystrophy: a comparative review. BioDrugs 38:95\u2013119","journal-title":"BioDrugs"},{"key":"273_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1172\/JCI40373","volume":"120","author":"FS Tedesco","year":"2010","unstructured":"Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120:11\u201319","journal-title":"J Clin Invest"},{"key":"273_CR56","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4:1441\u20131444","journal-title":"Nat Med"},{"key":"273_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/384349a0","volume":"384","author":"JM Tinsley","year":"1996","unstructured":"Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384:349\u2013353","journal-title":"Nature"},{"key":"273_CR58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.scr.2017.10.023","volume":"25","author":"T Uchimura","year":"2017","unstructured":"Uchimura T, Otomo J, Sato M, Sakurai H (2017) A human iPS cell myogenic differentiation system permitting high-throughput drug screening. Stem Cell Res 25:98\u2013106","journal-title":"Stem Cell Res"},{"key":"273_CR59","doi-asserted-by":"publisher","first-page":"16474","DOI":"10.1073\/pnas.1307680110","volume":"110","author":"J von Maltzahn","year":"2013","unstructured":"von Maltzahn J, Jones AE, Parks RJ, Rudnicki MA (2013) Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Proc Natl Acad Sci USA 110:16474\u201316479","journal-title":"Proc Natl Acad Sci USA"},{"key":"273_CR60","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/mt.2012.35","volume":"20","author":"L Wang","year":"2012","unstructured":"Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, Guttridge DC, Sun H, Wang H (2012) Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 20:1222\u20131233","journal-title":"Mol Ther"},{"key":"273_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S et al (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447:87\u201391","journal-title":"Nature"},{"key":"273_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8713","volume":"6","author":"R Wu","year":"2015","unstructured":"Wu R, Li H, Zhai L, Zou X, Meng J, Zhong R, Li C, Wang H, Zhang Y, Zhu D (2015) MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice. Nat Commun 6:7713","journal-title":"Nat Commun"},{"key":"273_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1124\/jpet.113.211169","volume":"349","author":"BC Yaden","year":"2014","unstructured":"Yaden BC, Croy JE, Wang Y, Wilson JM, Datta-Mannan A, Shetler P, Milner A, Bryant HU, Andrews J, Dai G et al (2014) Follistatin: a novel therapeutic for the improvement of muscle regeneration. J Pharm Exp Ther 349:355\u2013371","journal-title":"J Pharm Exp Ther"},{"key":"273_CR64","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/cbic.201200506","volume":"13","author":"A Yahara","year":"2012","unstructured":"Yahara A, Shrestha AR, Yamamoto T, Hari Y, Osawa T, Yamaguchi M, Nishida M, Kodama T, Obika S (2012) Amido-bridged nucleic acids (AmNAs): synthesis, duplex stability, nuclease resistance, and in vitro antisense potency. Chembiochem 13:2513\u20132516","journal-title":"Chembiochem"},{"key":"273_CR65","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1039\/C5OB00242G","volume":"13","author":"T Yamamoto","year":"2015","unstructured":"Yamamoto T, Yahara A, Waki R, Yasuhara H, Wada F, Harada-Shiba M, Obika S (2015) Amido-bridged nucleic acids with small hydrophobic residues enhance hepatic tropism of antisense oligonucleotides in vivo. Org Biomol Chem 13:3757\u20133765","journal-title":"Org Biomol Chem"},{"key":"273_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16017-5","volume":"12","author":"T Yamasaki","year":"2022","unstructured":"Yamasaki T, Horie T, Koyama S, Nakao T, Baba O, Kimura M, Sowa N, Sakamoto K, Yamazaki K, Obika S et al (2022) Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways. Sci Rep 12:11984","journal-title":"Sci Rep"},{"key":"273_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14063-y","volume":"7","author":"T Yoshida","year":"2017","unstructured":"Yoshida T, Awaya T, Jonouchi T, Kimura R, Kimura S, Era T, Heike T, Sakurai H (2017) A skeletal muscle model of infantile-onset pompe disease with patient-specific iPS cells. Sci Rep 7:13473","journal-title":"Sci Rep"},{"key":"273_CR68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.matbio.2018.07.003","volume":"74","author":"S Zanotti","year":"2018","unstructured":"Zanotti S, Gibertini S, Blasevich F, Bragato C, Ruggieri A, Saredi S, Fabbri M, Bernasconi P, Maggi L, Mantegazza R et al (2018) Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis. Matrix Biol 74:77\u2013100","journal-title":"Matrix Biol"},{"key":"273_CR69","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bbadis.2015.04.013","volume":"1852","author":"S Zanotti","year":"2015","unstructured":"Zanotti S, Gibertini S, Curcio M, Savadori P, Pasanisi B, Morandi L, Cornelio F, Mantegazza R, Mora M (2015) Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta 1852:1451\u20131464","journal-title":"Biochim Biophys Acta"},{"key":"273_CR70","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ajpath.2011.04.008","volume":"179","author":"J Zhu","year":"2011","unstructured":"Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, Quintero AJ, Huard J (2011) Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol 179:915\u2013930","journal-title":"Am J Pathol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00273-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:46:32Z","timestamp":1779065192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00273-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,11]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00273-9","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JK, KOk, RF, AT, and TS are employees of Mitsubishi Tanabe Pharma Corporation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}